72579-0022 BEQALZI - CanMED: NDC

Product NDC:

72579-0022

Brand Name:

BEQALZI

Generic Name:

Sonrotoclax

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: SONROTOCLAX

Strength: 80.0

Unit: mg/1

Packages:

Code: 72579-0022-01

Description: 1 BLISTER PACK in 1 CARTON (72579-022-01) / 11 TABLET, FILM COATED in 1 BLISTER PACK

Effective Date: Aug. 31, 2026

Discontinued:

Code: 72579-0022-08

Description: 1 BOTTLE in 1 CARTON (72579-022-08) / 120 TABLET, FILM COATED in 1 BOTTLE

Effective Date: Aug. 31, 2026

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

BCL-2

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox